2020～2024年简阳市适龄女性宫颈癌和乳腺癌筛查结果及成本效果分析OA

Objective:To analyze and evaluate the screening outcomes and cost-effectiveness of the free cervical and breast cancer screening program(hereinafter referred to as the"two cancers")for women aged 35～64 in Jianyang from a health economics perspective,and to provide a scientific basis for the prevention and control of the two cancers,optimize health management,and support evidence-based decision-making.Methods:Using individual case data and quarterly re-ports from the Chengdu Reproductive Health Database for Women of Childbearing Age,statistical analysis was conducted on the detection rate,early diagnosis rate,treat-ment rate,and other screening results of the two cancers.The average cost of case detection(ACCD),the average cost of early case detection(ACECD),and the early detection cost index(EDCI)were calculated for cost-effectiveness analysis.Results:From 2020 to 2024,a total of 76,921 women aged 35～64 received free cervical cancer screening in Jianyang.The detection rates of cervical cancer,cervical precancerous lesions,and the combination of the two were 20.80/100,000,219.71/100,000,and 240.51/100,000,respectively.The early diagnosis rate and treatment rate were 91.35%and 100.00%,respectively.The early diagnosis rate increased year by year from 2020 to 2024(P<0.05).The ACCD was 28,101 yuan,the ACECD was 30,761 yuan,and the EDCI was 0.72.Meanwhile,30,834 women aged 35～64 years underwent free breast cancer screening in Jianyang during the same period.The detection rate,early diagnosis rate and treatment rate of breast cancer were 64.86/100,0 00,75.00%,and 100.00%,respectively.The ACCD was 121,794 yuan,the ACECD was 162,392 yuan,and the EDCI was 3.80.Conclusion:The screening for the two cancers among eligible women in Jian-yang from 2020 to 2024 has achieved good outcomes and high cost-effectiveness,especially for cervical cancer.It is recom-mended to further expand the coverage.